SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model
about
The emerging roles of GPRC5A in diseasesThe restrained expression of NF-kB in renal tissue ameliorates folic acid induced acute kidney injury in miceIl-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migrationTumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients.Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2KRole of circulating miRNAs as biomarkers in idiopathic pulmonary arterial hypertension: possible relevance of miR-23a.IL22/IL-22R pathway induces cell survival in human glioblastoma cells.Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma.SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy.Trastuzumab resistance induces EMT to transform HER2(+) PTEN(-) to a triple negative breast cancer that requires unique treatment optionsp53 inhibits the expression of p125 and the methylation of POLD1 gene promoter by downregulating the Sp1-induced DNMT1 activities in breast cancer.Modeling synovial sarcoma metastasis in the mouse: PI3'-lipid signaling and inflammation.Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancerAnti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3Dysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer Treatment.Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade.The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition.lnflammation-induced epigenetic switches in cancer.Biological and clinical significance of cancer stem cell plasticityFunctional SNP in stem of mir-146a affects Her2 status and breast cancer survival.Does PTEN gene mutation play any role in Li-Fraumeni syndrome.RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer.A transcriptomic insight into the impacts of mast cells in lung, breast, and colon cancers.Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells.Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment.Peptides as Therapeutic Agents for Inflammatory-Related Diseases
P2860
Q27020926-2AEC4B2B-E366-4D96-B8C3-5DB115C4C2AAQ27318623-259D3586-5C68-4D89-B837-9B6EA0AF2565Q30660919-38225D80-4E39-41C8-999C-3B3820BEB693Q33709814-944C1E17-346E-40AF-A900-A523E0624939Q34880928-5081557F-CA75-4163-943E-954EE634BEFEQ35169973-432C892F-5995-4BD2-9C09-70833AA6D092Q35203455-93D2801F-232E-402B-96B6-D6012347A6C8Q35828688-5ECD2CCC-FAC5-4EAB-B523-BAFECC276B0BQ36195422-8F35206F-CE03-44E0-8D97-139709915AEFQ36237715-6E51183D-6081-46EE-B516-B8AA9F3EC487Q36688072-D3622352-DC5E-4353-A378-97A0E45D682BQ37500347-BF6B8DD1-F379-4258-8EE4-EAD8F764C667Q37588298-5A4E624A-C447-43BB-B7AA-BEB291454A6CQ37629076-8BEAC31B-F2D8-41F1-A360-DA6F488FB29FQ37630276-6D0C18FA-7B68-43AD-B7E5-86BAEFE2ACEAQ37741335-CB121F2F-70C6-4853-97E4-23EBEBF4C326Q38264904-AE8D8D62-5E91-414F-A2B7-999412FE4797Q38591056-3C57A764-6EAE-4B67-A7F9-324D8BCB3A57Q38757074-3EA25809-C0E8-4D66-A908-CC7B8D74C981Q38840131-96A76D24-5330-4EFF-A225-B671F3C81FF2Q42383055-4EDC236F-D772-40C9-BD4F-31730AB313E9Q42505152-2C7BB039-19E4-454C-88B5-CBAB6D40C28AQ47306770-F754A976-E15D-4DB8-AA06-D535FC32E093Q47867377-9E5C7164-3AB7-4281-9CBF-677F0A4DF632Q55396890-7CC259DE-AD40-4357-AB28-30BE26D3D2CAQ58749714-FA3ABB9D-8ACC-4594-9C15-2EA091EC34E5
P2860
SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
SOCS3-mediated regulation of i ...... e negative breast cancer model
@ast
SOCS3-mediated regulation of i ...... e negative breast cancer model
@en
SOCS3-mediated regulation of i ...... e negative breast cancer model
@nl
type
label
SOCS3-mediated regulation of i ...... e negative breast cancer model
@ast
SOCS3-mediated regulation of i ...... e negative breast cancer model
@en
SOCS3-mediated regulation of i ...... e negative breast cancer model
@nl
prefLabel
SOCS3-mediated regulation of i ...... e negative breast cancer model
@ast
SOCS3-mediated regulation of i ...... e negative breast cancer model
@en
SOCS3-mediated regulation of i ...... e negative breast cancer model
@nl
P2093
P2860
P50
P356
P1433
P1476
SOCS3-mediated regulation of i ...... e negative breast cancer model
@en
P2093
A A Quraishi
D G Thomas
N Tawakkol
P2860
P2888
P304
P356
10.1038/ONC.2014.4
P407
P577
2014-02-17T00:00:00Z
P5875
P6179
1004019682